Clinical Trial Update: Phase II Study of CG100649 for Primary Osteoarthritis in Male Subjects [Phase 2]

View source ↗

Summary

A Phase II clinical trial update for CG100649 in male subjects with osteoarthritis of the knee or hip; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• CG100649 (CG100649)

Snippet

Sponsor: CrystalGenomics, Inc. | Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip | Phase 2 | Status: UNKNOWN